A Study to Characterize the Clinical Course of Pregnant Women and Children at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn
Conditions
- Early Onset Severe Hemolytic Disease of the Fetus and Newborn (EOS-HDFN)
- Erythroblastosis, Fetal
Interventions
Sponsor
Janssen Research & Development, LLC